SECsense Logo

Vaxart, Inc. 8-K Filing Report: Major Updates & Insights

$VXRT
Form 8-K
Filed on: 2025-02-10
Source
Vaxart, Inc. 8-K Filing Report: Major Updates & Insights

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Vaxart, Inc.
  • CIK Number: 0000072444
  • SEC File Number: 001-35285
  • EIN: 59-1212264
  • Address: 170 Harbor Way, Suite 300, South San Francisco, CA 94080
  • Phone Number: 650-550-3500
  1. Filing Type:
  • Form Type: 8-K (This form is used by companies to announce major events that shareholders should know about.)
  1. Filing Date:
  • Date of Filing: February 7, 2025
  1. Stock Information:
  • Common Stock Ticker: VXRT
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Reporting Date: February 7, 2025 (the start and end date of the reported period are the same)

Insights:

  • The report indicates a major event or update related to Vaxart, Inc. as per the 8-K filing, which is a prompt disclosure requirement under SEC regulations.
  • The company's details, such as its address and contact information, suggest that it is based in South San Francisco, California, which is a hub for biotechnology firms.
  • The fact that this is an 8-K filing suggests that the information within may pertain to significant corporate actions such as acquisitions, financial results, or other key developments that could impact stock performance.

Overall, further analysis would require details on the specific events being reported in the 8-K filing, as that would provide deeper insights into the company's current situation and potential future performance.